|
|
||||||||||
|
J Am Coll Cardiol, 1993; 22:1788-1794 © 1993 by the American College of Cardiology Foundation |
Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
OBJECTIVES. This study was conducted to determine the role of insulin-dependent and noninsulin-dependent diabetes in the prognosis of patients after myocardial infarction and treatment with fibrinolytic agents. BACKGROUND. Several studies have shown that diabetic patients have a high mortality rate after acute myocardial infarction. However, the impact of diabetes on survival in patients treated with fibrinolytic agents is still undefined. It is also not known whether the type of diabetes or gender affects prognosis. METHODS. We analyzed prevalence and prognostic significance of a history of diabetes in patients enrolled in the GISSI-2 study, all of whom received fibrinolytic agents. The incidence of deaths in the hospital and at 6 months after study entry was computed for patients without diabetes and for insulin-dependent and noninsulin-dependent diabetic patients; relative risks were evaluated by univariate and multivariate analysis. RESULTS. Information on diabetic status was available for 11,667 patients, 94.2% of those randomized in the GISSI-2 study. The prevalence of diabetes was higher in women than in men (8.75% vs. 1.85%, p < 0.01 for insulin-dependent and 23.7% vs. 13.8%, p < 0.01 for noninsulin-dependent diabetic patients). The type of fibrinolytic agent did not affect mortality rates; the increase in in-hospital mortality of diabetic patients was moderate and similar for men with insulin- and noninsulin-dependent diabetes (8.7% and 10.1%, respectively, vs. 5.8% in nondiabetic patients); in women, mortality was markedly higher for insulin-dependent and only slightly higher for noninsulin-dependent diabetic patients (24.0% and 15.8%, respectively, vs. 13.9% for nondiabetic patients). The adjusted relative risks were 1.9 (95% confidence interval 1.2 to 2.9) for insulin-dependent diabetic women and 1.4 (95% confidence interval 1.1 to 1.8) for noninsulin-dependent diabetic men. The mortality rate after discharge showed a similar gender difference, and in insulin-dependent diabetic women, prognosis was ominous even in the absence of left ventricular damage before discharge. CONCLUSIONS. A history of diabetes is associated with a worse prognosis after myocardial infarction, even in patients treated with fibrinolytic agents. Gender and type of diabetes appear to be critical in affecting survival. In men, both insulin-dependent and noninsulin-dependent diabetes are associated with a moderately higher mortality rate; in women, insulin-dependent diabetes is, in itself, a strong risk factor for death after myocardial infarction.
This article has been cited by other articles:
![]() |
P. Ferdinandy, R. Schulz, and G. F. Baxter Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning Pharmacol. Rev., December 1, 2007; 59(4): 418 - 458. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Chowdhry, H. A. Vohra, and M. Galinanes Diabetes increases apoptosis and necrosis in both ischemic and nonischemic human myocardium: Role of caspases and poly-adenosine diphosphate-ribose polymerase J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 124 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Pittas, R. D. Siegel, and J. Lau Insulin Therapy and In-Hospital Mortality in Critically Ill Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials JPEN J Parenter Enteral Nutr, March 1, 2006; 30(2): 164 - 172. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Gilbert, K. Connelly, D. J. Kelly, C. A. Pollock, and H. Krum Heart Failure and Nephropathy: Catastrophic and Interrelated Complications of Diabetes Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 193 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. X. Brogan Jr, E. D. Peterson, J. Mulgund, D. L. Bhatt, E. M. Ohman, W. B. Gibler, C. V. Pollack Jr, M. E. Farkouh, and M. T. Roe Treatment Disparities in the Care of Patients With and Without Diabetes Presenting With Non-ST-Segment Elevation Acute Coronary Syndromes Diabetes Care, January 1, 2006; 29(1): 9 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Murcia, C. H. Hennekens, G. A. Lamas, M. Jimenez-Navarro, J. L. Rouleau, G. C. Flaker, S. Goldman, H. Skali, E. Braunwald, and M. A. Pfeffer Impact of Diabetes on Mortality in Patients With Myocardial Infarction and Left Ventricular Dysfunction Arch Intern Med, November 8, 2004; 164(20): 2273 - 2279. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Pittas, R. D. Siegel, and J. Lau Insulin Therapy for Critically Ill Hospitalized Patients: A Meta-analysis of Randomized Controlled Trials Arch Intern Med, October 11, 2004; 164(18): 2005 - 2011. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Galinanes and A. G Fowler Role of clinical pathologies in myocardial injury following ischaemia and reperfusion Cardiovasc Res, February 15, 2004; 61(3): 512 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tikiz, U. Tezcan, M. Ileri, Y. Balbay, R. Atak, and E. Kutuk Diabetes Mellitus Adversely Affects the Outcomes of Thrombolytic Therapy in Patients with Acute Myocardial Infarction Angiology, July 1, 2003; 54(4): 449 - 456. [Abstract] [PDF] |
||||
![]() |
C. Borghi, S. Bacchelli, D. D. Esposti, and E. Ambrosioni Effects of the Early ACE Inhibition in Diabetic Nonthrombolyzed Patients With Anterior Acute Myocardial Infarction Diabetes Care, June 1, 2003; 26(6): 1862 - 1868. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chyun, V. Vaccarino, J. Murillo, L. H. Young, and H. M. Krumholz Cardiac Outcomes After Myocardial Infarction in Elderly Patients With Diabetes Mellitus Am. J. Crit. Care., November 1, 2002; 11(6): 504 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Kanaya, D. Grady, and E. Barrett-Connor Explaining the Sex Difference in Coronary Heart Disease Mortality Among Patients With Type 2 Diabetes Mellitus: A Meta-analysis Arch Intern Med, August 12, 2002; 162(15): 1737 - 1745. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Verma, A. Maitland, R. D. Weisel, P. W. M. Fedak, S.-H. Li, D. A. G. Mickle, R.-K. Li, L. Ko, and V. Rao Increased endothelin-1 production in diabetic patients after cardioplegic arrest and reperfusion impairs coronary vascular reactivity: Reversal by means of endothelin antagonism J. Thorac. Cardiovasc. Surg., June 1, 2002; 123(6): 1114 - 1119. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Beckman, M. A. Creager, and P. Libby Diabetes and Atherosclerosis: Epidemiology, Pathophysiology, and Management JAMA, May 15, 2002; 287(19): 2570 - 2581. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Marchioli, F Avanzini, F Barzi, C Chieffo, A Di Castelnuovo, M.G Franzosi, E Geraci, A.P Maggioni, R.M Marfisi, N Mininni, et al. Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations; GISSI-Prevenzione mortality risk chart Eur. Heart J., November 2, 2001; 22(22): 2085 - 2103. [Abstract] [PDF] |
||||
![]() |
R. Bigi, A. Desideri, L. Cortigiani, J. J. Bax, L. Celegon, and C. Fiorentini Stress Echocardiography for Risk Stratification of Diabetic Patients With Known or Suspected Coronary Artery Disease Diabetes Care, September 1, 2001; 24(9): 1596 - 1601. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Moreno, E. Garcia, J. Zamorano, J.-L. Lopez-Sendon, and L. Sanchez-Harguindey Acute myocardial infarcation in diabetic patients. Are we acutally doing bad? Eur. Heart J., August 1, 2001; 22(15): 1359 - 1361. [Abstract] [PDF] |
||||
![]() |
K. J. Mukamal, R. W. Nesto, M. C. Cohen, J. E. Muller, M. Maclure, J. B. Sherwood, and M. A. Mittleman Impact of Diabetes on Long-Term Survival After Acute Myocardial Infarction: Comparability of risk with prior myocardial infarction Diabetes Care, August 1, 2001; 24(8): 1422 - 1427. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Ishihara, H Sato, T Kawagoe, Y Shimatani, S Kurisu, K Nishioka, Y Kouno, T Umemura, and S Nakamura Impact of diabetes mellitus on long term survival after acute myocardial infarction in patients with single vessel disease Heart, August 1, 2001; 86(2): 133 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Gustafsson, P Hildebrandt, M Seibaek, T Melchior, C Torp-Pedersen, L Kober, and P Kaiser-Nielsen Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen Eur. Heart J., December 1, 2000; 21(23): 1937 - 1943. [Abstract] [PDF] |
||||
![]() |
H. M. Colhoun, M. B. Rubens, S. R. Underwood, and J. H. Fuller The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2160 - 2167. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Shindler, S. T. Palmeri, T. A. Antonelli, L. A. Sleeper, J. Boland, T. P. Cocke, J. S. Hochman, and for the SHOCK Investigators Diabetes mellitus in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry J. Am. Coll. Cardiol., September 1, 2000; 36(3_Suppl_A): 1097 - 1103. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hammoud, J.-F. Tanguay, and M. G. Bourassa Management of coronary artery disease: therapeutic options in patients with diabetes J. Am. Coll. Cardiol., August 1, 2000; 36(2): 355 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Jones, W. G. Girod, D. N. Granger, A. J. Palazzo, and D. J. Lefer Reperfusion injury is not affected by blockade of P-selectin in the diabetic mouse heart Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H763 - H769. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gustafsson, C. Torp-Pedersen, L. Kober, F. Gustafsson, P. Hildebrandt, and on behalf of the Trace Study Group Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction J. Am. Coll. Cardiol., July 1, 1999; 34(1): 83 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Torp-Pedersen, L. Kober, S. S. Gottlieb, R. J. McCarter, and R. A. Vogel Beta-Blockers after Myocardial Infarction N. Engl. J. Med., December 31, 1998; 339(27): 2022 - 2023. [Full Text] |
||||
![]() |
S. S. Gottlieb, R. J. McCarter, and R. A. Vogel Effect of Beta-Blockade on Mortality among High-Risk and Low-Risk Patients after Myocardial Infarction N. Engl. J. Med., August 20, 1998; 339(8): 489 - 497. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zuanetti, R. Latini, A. P. Maggioni, M. Franzosi, L. Santoro, G. Tognoni, and G. 3 Investigators Effect of the ACE Inhibitor Lisinopril on Mortality in Diabetic Patients With Acute Myocardial Infarction : Data From the GISSI-3 Study Circulation, December 16, 1997; 96(12): 4239 - 4245. [Abstract] [Full Text] |
||||
![]() |
G. Berton, T. Citro, R. Palmieri, S. Petucco, S. Renzo De Toni, and P. Palatini Albumin Excretion Rate Increases During Acute Myocardial Infarction and Strongly Predicts Early Mortality Circulation, November 18, 1997; 96(10): 3338 - 3345. [Abstract] [Full Text] |
||||
![]() |
P. S. Douglas and G. S. Ginsburg The Evaluation of Chest Pain in Women N. Engl. J. Med., May 16, 1996; 334(20): 1311 - 1315. [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |